DAIICHI SANKYO COMPANY LIMITED / Amgen Inc. / Ligand / Immediate Release Company / Tokyo Stock Exchange / /
Country
Japan / /
Event
FDA Phase / M&A / /
IndustryTerm
osteoporosis treatment / breast cancer therapy / healthcare professionals / treatment of rare diseases / /
MedicalCondition
rare diseases / multiple myeloma / Giant Cell Tumor / osteoporosis / rheumatoid arthritis / postoperative adjuvant breast cancer / solid tumors / bone metastases / /
MedicalTreatment
breast cancer therapy / /
Organization
Ministry of Health / /
Person
Joji Nakayama / Noriaki Ishida / / /
Position
Representative / essential mediator / Director / President & CEO / Corporate Officer / Vice President / Corporate Communications Department Telephone / /
Microsoft Word - 20140523_RANMARK for Treatment of Giant Cell Tumor of Bone_final2.docx